Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kiyoshi Yoshimura

Showing results (91-100 of 108) with videos related to

Pageof 11
Sort By:
Cancer Research|September 10, 2009
Integrin alpha2 mediates selective metastasis to the liverKiyoshi Yoshimura, Kristen F Meckel, Lindsay S Laird, et al.
Anticancer Research|July 31, 2014
Predictive biomarkers for the outcome of vaccination of five therapeutic epitope peptides for colorectal cancerShoichi Hazama, Hiroko Takenouchi, Ryouichi Tsunedomi, et al.
Frontiers in Immunology|April 13, 2026
Correction: Tumor <i>Akkermansia muciniphila</i> predicts clinical response to immune checkpoint inhibitors in non-small-cell lung cancer patients with low PD-L1 expressionTakashi Shimizu, Ryotaro Ohkuma, Mayumi Homma, et al.
Oncology Reports|July 7, 2020
High expression levels of polymeric immunoglobulin receptor are correlated with chemoresistance and poor prognosis in pancreatic cancerRyotaro Ohkuma, Erica Yada, Shumpei Ishikawa, et al.
International Journal of Cancer|June 6, 2025
Combination therapy with levofloxacin and the probiotic Clostridium butyricum MIYAIRI 588 enhances immune checkpoint inhibitor efficacyKohei Tajima, Masahiro Hosonuma, Eiji Funayama, et al.
Microbiology Spectrum|January 16, 2025
Association between the <i>ABCC11</i> gene polymorphism-determined earwax properties and external auditory canal microbiota in healthy adultsYasunobu Amari, Masahiro Hosonuma, Takuya Mizukami, et al.
Medicine|June 11, 2021
A case report on severe nivolumab-induced adverse events similar to primary sclerosing cholangitis refractory to immunosuppressive therapyYuya Hirasawa, Kiyoshi Yoshimura, Hiroto Matsui, et al.
Anticancer Research|December 30, 2023
Non-classical Monocytes Enhance the Efficacy of Immune Checkpoint Inhibitors on Colon Cancer in a Syngeneic Mouse ModelTsubasa Goshima, Katsuaki Ieguchi, Nobuyuki Onishi, et al.
Cancer Science|January 23, 2024
Nivolumab receptor occupancy on effector regulatory T cells predicts clinical benefitMasahiro Hosonuma, Yuya Hirasawa, Atsuo Kuramasu, et al.
Frontiers in Immunology|May 19, 2023
<i>Turicibacter</i> and <i>Acidaminococcus</i> predict immune-related adverse events and efficacy of immune checkpoint inhibitorKazuyuki Hamada, Junya Isobe, Kouya Hattori, et al.
Pageof 11

Showing results (91-100 of 108) with videos related to

Sort By:
Pageof 11
Cancer Research|September 10, 2009
Integrin alpha2 mediates selective metastasis to the liverKiyoshi Yoshimura, Kristen F Meckel, Lindsay S Laird, et al.
Anticancer Research|July 31, 2014
Predictive biomarkers for the outcome of vaccination of five therapeutic epitope peptides for colorectal cancerShoichi Hazama, Hiroko Takenouchi, Ryouichi Tsunedomi, et al.
Frontiers in Immunology|April 13, 2026
Correction: Tumor <i>Akkermansia muciniphila</i> predicts clinical response to immune checkpoint inhibitors in non-small-cell lung cancer patients with low PD-L1 expressionTakashi Shimizu, Ryotaro Ohkuma, Mayumi Homma, et al.
Oncology Reports|July 7, 2020
High expression levels of polymeric immunoglobulin receptor are correlated with chemoresistance and poor prognosis in pancreatic cancerRyotaro Ohkuma, Erica Yada, Shumpei Ishikawa, et al.
International Journal of Cancer|June 6, 2025
Combination therapy with levofloxacin and the probiotic Clostridium butyricum MIYAIRI 588 enhances immune checkpoint inhibitor efficacyKohei Tajima, Masahiro Hosonuma, Eiji Funayama, et al.
Microbiology Spectrum|January 16, 2025
Association between the <i>ABCC11</i> gene polymorphism-determined earwax properties and external auditory canal microbiota in healthy adultsYasunobu Amari, Masahiro Hosonuma, Takuya Mizukami, et al.
Medicine|June 11, 2021
A case report on severe nivolumab-induced adverse events similar to primary sclerosing cholangitis refractory to immunosuppressive therapyYuya Hirasawa, Kiyoshi Yoshimura, Hiroto Matsui, et al.
Anticancer Research|December 30, 2023
Non-classical Monocytes Enhance the Efficacy of Immune Checkpoint Inhibitors on Colon Cancer in a Syngeneic Mouse ModelTsubasa Goshima, Katsuaki Ieguchi, Nobuyuki Onishi, et al.
Cancer Science|January 23, 2024
Nivolumab receptor occupancy on effector regulatory T cells predicts clinical benefitMasahiro Hosonuma, Yuya Hirasawa, Atsuo Kuramasu, et al.
Frontiers in Immunology|May 19, 2023
<i>Turicibacter</i> and <i>Acidaminococcus</i> predict immune-related adverse events and efficacy of immune checkpoint inhibitorKazuyuki Hamada, Junya Isobe, Kouya Hattori, et al.
Pageof 11